Search Videos and More
Course
Complex Patient Case Review for Oncologic and Benign Urology
Live Webinar | 5:00 PM - 6:00 PM EDT | Wednesday, May 21, 2025
Course
Advanced Heart Failure Therapies: Who, When, & What
Of the more than 6 million Americans living with heart failure, approximately 10% have advanced heart failure or Stage D Heart Failure. Patients in this category should be evaluated for advanced therapy options including heart transplant and LVAD therapy. This educational activity will focus on the identification of patients with Stage D Heart Failure utilizing basic variables from history, lab data, imaging, physical exam, and current regimen.
Course
Cardiotoxic Therapies in Cancer Treatment: What Providers Need to Know
Thanks to advances in treatment, more people are surviving cancer and living into their 60s, 70s, and beyond. But with this increase in survival has also come an increase in cardiovascular disease for this population. As a result, providers must keep cardiotoxicity in mind as they implement treatment plans for their patients, says Eman Hamad, MD, director of Cardio-Oncology and the Advanced Heart Failure and Transplant Program at Temple University Hospital.
News
March Quarterly Impact Report: Temple Healthy Chest Initiative
screenings since program inception. Research shows that roughly 70% of patients undergoing lung cancer screening will have some radiographic abnormality in their scan results. This report outlines steps the Temple Healthy Chest Initiative has taken to scale screening efforts in order to detect a wide range of chest conditions at earlier stages.
Course
The Latest in CTEPH Diagnosis and Treatment
Research has shown that around 3.8% of patients with pulmonary embolism go on to develop chronic thromboembolic pulmonary hypertension (CTEPH). But what are the risk factors, and how can providers best manage these patients?
Course
Devices Can Play a Key Role in Managing Heart Failure
Even with gold-standard treatment, heart failure causes tremendous distress in patients, with debilitating symptoms and pain that can impact their day-to-day functioning, social relationships, and mental health. Studies have found that the quality of life for heart failure patients is comparable to people on dialysis, and five-year survival estimates are on par with some cancers.
Course
2025 GOLD International COPD Conference
Hosted in partnership by The Temple Lung Center and the Global Initiative for Chronic Obstructive Lung Disease (GOLD), this conference will be presented in a hybrid format with in-person sessions virtually simulcast to a global audience of healthcare providers involved in the care and management of people with COPD. Learn alongside other dedicated COPD practitioners, and hear directly from leading experts and researchers.
News
Temple Lung Center: Advances in Lung Care and Research in 2024
The Temple Lung Center continued to set the standard in lung health throughout 2024, delivering exceptional clinical care and advancing lung disease research. Through expanded screening programs and innovative clinical trials, our multidisciplinary team—including pulmonologists, thoracic surgeons, and other specialists—provided patients with breakthrough options for diagnosing and treating even the most complex lung conditions.
News
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective therapies, we bring hope to patients with serious and debilitating lung diseases.
Course
Evaluation of Dyspnea
Dyspnea and dyspnea on exertion are among the most common patient complaints both in the office and in the hospital setting. While in-hospital evaluations tend to have a more acute focus, outpatient office evaluations of dyspnea tend to be more varied and nuanced in their etiology. Pulmonary function testing and cardiopulmonary exercise testing are important modalities to help differentiate causes of dyspnea.
Video
LDCT+: A New Approach in Early Lung Disease Detection - Webinar
View Archive of this live webinar | Annual low-dose computed tomography (LDCT) screening has transformed early lung cancer detection, yet many patients remain underdiagnosed for coexisting conditions like COPD—an independent risk factor for lung cancer and a major comorbidity affecting survival.
Course
Interstitial Lung Disease (ILD) and Associated Pulmonary Hypertension
Interstitial lung disease (ILD) is a commonly encountered disease state. Patients who develop ILD associated with pulmonary hypertension have an increased mortality risk. This program aims to review the classification of commonly encountered interstitial lung diseases. Secondly, to describe the pathophysiology that leads to the development of ILD associated pulmonary hypertension. Lastly, to review a diagnostic approach to ILD associated pulmonary hypertension along with treatment options.